ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MLTX MoonLake Immunotherapeutics

45.26
2.69 (6.32%)
May 03 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 376,063
Bid Price 42.23
Ask Price 45.88
News -
Day High 45.465

Low
20.3501

52 Week Range

High
64.98

Day Low 43.405
Share Name Share Symbol Market Stock Type
MoonLake Immunotherapeutics MLTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
2.69 6.32% 45.26 19:00:00
Open Price Low Price High Price Close Price Previous Close
43.51 43.405 45.465 45.26 42.57
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
6,404 376,063 US$ 44.24 US$ 16,636,682 - 20.3501 - 64.98
Last Trade Type Quantity Price Currency
18:51:39 1 US$ 45.25 USD

MoonLake Immunotherapeut... (MLTX) Options Flow Summary

Overall Flow

Bullish

Net Premium

41k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

MoonLake Immunotherapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.9B 63.89M - 0 -44.08M -0.69 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

MoonLake Immunotherapeut... News

Date Time Source News Article
4/10/202406:00Business WireMoonLake Immunotherapeutics Inks Three-Year Technology..
3/11/202407:01Edgar (US Regulatory)Form 8-K - Current report
3/10/202411:00GlobeNewswire Inc.MoonLake announces significant improvements with Nanobody®..
3/04/202407:00GlobeNewswire Inc.MoonLake Immunotherapeutics to present MIRA trial data of..
2/29/202418:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/29/202418:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/29/202407:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/29/202407:03Edgar (US Regulatory)Form 8-K - Current report
2/29/202407:00GlobeNewswire Inc.MoonLake Immunotherapeutics Reports Full Year 2023 Financial..
2/26/202408:00Edgar (US Regulatory)Form 8-K - Current report
2/26/202407:00GlobeNewswire Inc.MoonLake Immunotherapeutics Announces Positive Feedback from..
2/23/202415:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No MLTX Message Board. Create One! See More Posts on MLTX Message Board See More Message Board Posts

Historical MLTX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week42.3745.46540.4542.20287,5682.896.82%
1 Month46.0247.7240.4543.72336,814-0.76-1.65%
3 Months61.8264.9840.4549.11481,818-16.56-26.79%
6 Months47.8864.9835.1149.02564,031-2.62-5.47%
1 Year20.8964.9820.350148.60598,10924.37116.66%
3 Years12.3764.984.2542.01356,50732.89265.89%
5 Years12.3764.984.2542.01356,50732.89265.89%

MoonLake Immunotherapeut... Description

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

Your Recent History

Delayed Upgrade Clock